These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

128 related articles for article (PubMed ID: 7674460)

  • 1. A non-invasive and quantitative method for the study of tissue injury caused by intramuscular injection of drugs in horses.
    Toutain PL; Lassourd V; Costes G; Alvinerie M; Bret L; Lefebvre HP; Braun JP
    J Vet Pharmacol Ther; 1995 Jun; 18(3):226-35. PubMed ID: 7674460
    [TBL] [Abstract][Full Text] [Related]  

  • 2. In vivo non-invasive quantification of muscle damage following a single intramuscular injection of phenylbutazone in sheep.
    Houpert P; Serthelon JP; Lefebvre HP; Toutain PL; Braun JP
    Vet Hum Toxicol; 1995 Apr; 37(2):105-10. PubMed ID: 7631487
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Non-invasive and quantitative evaluation of post-injection muscle damage by pharmacokinetic analysis of creatine kinase release.
    Lefebvre HP; Laroute V; Braun JP; Lassourd V; Toutain PL
    Vet Res; 1996; 27(4-5):343-61. PubMed ID: 8822606
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Simultaneous and minimally invasive assessment of muscle tolerance and bioavailability of different volumes of an intramuscular formulation in the same animals.
    Ferre PJ; Laroute V; Braun JP; Cazaux J; Toutain PL; Lefebvre HP
    J Anim Sci; 2006 May; 84(5):1295-301. PubMed ID: 16612034
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The effect of inflammation on the disposition of phenylbutazone in thoroughbred horses.
    Mills PC; Ng JC; Auer DE
    J Vet Pharmacol Ther; 1996 Dec; 19(6):475-81. PubMed ID: 8971677
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Disposition of creatine kinase activity in dog plasma following intravenous and intramuscular injection of skeletal muscle homogenates.
    Aktas M; Lefebvre HP; Toutain PL; Braun JP
    J Vet Pharmacol Ther; 1995 Feb; 18(1):1-6. PubMed ID: 7752299
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The intramuscular bioavailability of a phenylbutazone preparation in the horse.
    Landuyt J; Delbeke FT; Debackere M
    J Vet Pharmacol Ther; 1993 Dec; 16(4):494-500. PubMed ID: 8126767
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Kinetic evaluation of muscle damage during exercise by calculation of amount of creatine kinase released.
    Volfinger L; Lassourd V; Michaux JM; Braun JP; Toutain PL
    Am J Physiol; 1994 Feb; 266(2 Pt 2):R434-41. PubMed ID: 8141400
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Pharmacokinetics of danofloxacin in horses after intravenous, intramuscular and intragastric administration.
    Fernández-Varón E; Ayala I; Marín P; Carrión A; Martos N; Escudero E; Cárceles CM
    Equine Vet J; 2006 Jul; 38(4):342-6. PubMed ID: 16866202
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Bioavailability of muscle creatine kinase in sheep. Application to the assessment of local tolerance to injectable veterinary formulations].
    Verlinde V; Mikaelian I; Laurentie M; Sanders P; Poul JM
    Vet Res; 1996; 27(2):133-46. PubMed ID: 8721293
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Pharmacokinetics of tildipirosin in horses after intravenous and intramuscular administration and its potential muscle damage.
    Galecio JS; Escudero E; Badillo E; Marín P
    Res Vet Sci; 2022 Dec; 152():20-25. PubMed ID: 35908422
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Pharmacokinetics of phenylbutazone in neonatal foals.
    Wilcke JR; Crisman MV; Sams RA; Gerken DF
    Am J Vet Res; 1993 Dec; 54(12):2064-7. PubMed ID: 8116939
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Pharmacokinetics of phenylbutazone given intravenously or orally in mature Holstein bulls.
    Williams RJ; Smith JA; Boudinot FD; Knight AP
    Am J Vet Res; 1990 Mar; 51(3):367-70. PubMed ID: 2316911
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Pharmacodynamics and pharmacokinetics of phenylbutazone in calves.
    Arifah AK; Lees P
    J Vet Pharmacol Ther; 2002 Aug; 25(4):299-309. PubMed ID: 12213119
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Phenylbutazone blood and urine concentrations, pharmacokinetics, and effects on biomarkers of inflammation in horses following intravenous and oral administration of clinical doses.
    Knych HK; Arthur RM; McKemie DS; Seminoff K; Hamamoto-Hardman B; Kass PH
    Drug Test Anal; 2019 Jun; 11(6):792-803. PubMed ID: 30499176
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Disposition and tolerance of suxibuzone in horses.
    Jaraiz MV; Rodriguez C; San Andres MD; Gonzalez F; San Andres MI
    Equine Vet J; 1999 Sep; 31(5):411-6. PubMed ID: 10505957
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effect of an endurance-like exercise on the disposition and detection time of phenylbutazone and dexamethasone in the horse: application to medication control.
    Authie EC; Garcia P; Popot MA; Toutain PL; Doucet M
    Equine Vet J; 2010 Apr; 42(3):240-7. PubMed ID: 20486981
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effects of single-dose intravenous phenylbutazone on experimentally induced, reversible lameness in the horse.
    Foreman JH; Barange A; Lawrence LM; Hungerford LL
    J Vet Pharmacol Ther; 2008 Feb; 31(1):39-44. PubMed ID: 18177317
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Pharmacokinetics of enrofloxacin in horses after single intravenous and intramuscular administration.
    Kaartinen L; Panu S; Pyörälä S
    Equine Vet J; 1997 Sep; 29(5):378-81. PubMed ID: 9306065
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Pharmacokinetics of marbofloxacin in mature horses after single intravenous and intramuscular administration.
    Carretero M; Rodríguez C; San Andrés MI; Forés P; de Lucas JJ; Nieto J; Waxman S; San Andrés MD; González F
    Equine Vet J; 2002 Jul; 34(4):360-5. PubMed ID: 12117107
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.